Uncategorized Archives - Green Market Report

StaffStaffApril 10, 2019
img_northernswan-2.jpg

5min770

New Funding to Support Expansion of Cannabis Operations and Investments in Latin America and Europe

NEW YORK, April 10, 2019 /AxisWire/ Northern Swan Holdings, Inc. (“Northern Swan” or “the Company”), an investment firm focused on making transformative investments in the international cannabis industry, announced today the successful completion of a USD$58 million Series D financing, bringing the total amount of capital raised to date to USD$96 million. The oversubscribed round, which represents the largest capital raise to date for a Latin American-focused cannabis operation, was led by leading global institutional investors with a demonstrated track record in the industry.

“The closing of our Series D round validates our investment thesis, providing the capital necessary to fund rapid expansion and to capitalize on our key competitive advantages as a first-mover in the global medical cannabis market. Federally compliant in all jurisdictions in which we operate, Northern Swan is well-positioned to expand and diversify our cultivation assets as well as accelerate our mission to revolutionize the trade flows in the global medical cannabis industry,” noted Kyle Detwiler, CEO of Northern Swan.

Northern Swan will use the new funds to expand its existing Latin American operations, to invest in new low-cost, large-scale cannabis cultivation and processing centers and to build out distribution channels and brands in Europe, Latin America and North America. Northern Swan has invested in several companies spanning the global cannabis value chain including Clever Leaves, a leading vertically integrated licensed producer of medical cannabis in Colombia, Cansativa GmbH, a German cannabis distribution company and Lift & Co., a Canadian marketing and data company.

Cowen served as exclusive placement agent for the financing.

About Northern Swan
Northern Swan is an investment firm focused on transformative investments in the international cannabis industry in geographies where it is federally legal. With offices in New York, Toronto, Bogota, and Frankfurt, Northern Swan invests in and assists emerging companies in developing low-cost production capacity and distribution capabilities to improve distribution globally and generate brand value. Prior to founding Northern Swan, its management team has collectively invested in excess of $3 billion of capital at Blackstone, KKR, and Och-Ziff.

Forward-Looking Information
This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, the Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors.

Media Contact:
Gretchen Gailey
KCSA Strategic Communications
+1 347-487-6186
ggailey@kcsa.com


William SimpsonWilliam SimpsonJuly 17, 2018
donkey-and-elephant-holding-white-house-1280x647.jpg

3min6660

With President Trump signaling his likely support for the bipartisan Congressional effort to ease the U.S. ban on cannabis in legal markets, the country as a whole could benefit immensely.

By giving states the rights to determine the best course with cannabis, business valuations could go through the roof. For example, under the current laws, Golden Leaf Holdings, a cannabis company with cultivation, production, and retail operations that is publicly traded in Canada, is unable to be publicly traded on the Nasdaq. Conversely, Canadian cannabis companies are already allowed on the Nasdaq, giving them a significant advantage in the globally booming market.

The most significant progress for businesses would come with the easing of Internal Revenue Code 280E, which has, by and large, blocked cannabis businesses from tax deductions, credits and banking in general. The passing of this bill would be a tremendous step for states with legalized markets. American cannabis entities struggle daily to make retail an efficient platform, while barely breaking even under the current regulations. The Treasury Department demanding money from a market they deem illegal needs to end.

Most significantly, ending the federal ban could represent a step in the right direction towards addressing systemic criminal justice issues that unjustly target minorities, which is far more important than any business-related outcome.

This measure is far from a single, fix-all solution. Even if the bill became law tomorrow, businesses wouldn’t be able to reap the benefits right away. If cannabis remains a Schedule 1 narcotic, banks will continue to be hesitant to opening accounts for businesses. The same goes for standard business practices like shipping across state lines.

Furthermore, nothing federally-approved changes local and state laws. This means issues stemming from occupancy, zoning, packaging and other regulations will still loom over businesses. Too many voices in cannabis could leave the industry at the whim of political agendas and powerful competitor lobbies, including tobacco, alcohol and pharma.

While the bipartisan bill does provide the U.S. a step in the right direction for both the cannabis industry and its citizens, we must remember that it still is just one incremental step in the process. Plenty of work is left to be done on federal, state and local levels to revise regulations for businesses and citizens in states with legal markets. That said, the possible passing of the bill should be championed for the huge victory it would represent. With hope, it would be far from the last one to come.

 


greenflower.jpg

4min11040

Updated Streaming Video Platform Now Offer Free Access to 100’s Of Hours of New Expert-Led Cannabis Education Programs and New Original Content

 

Ventura, May 22, 2018/AxisWire/—Wanting to learn all that is possible about cannabis just became immensely easy.  The nation’s #1 cannabis learning platform, Green-Flower.com, is live and FREE with a brand-new streaming video platform and new library of original content designed to help people understand everything about cannabis.

With improved, more enriched entertaining video content featuring 600+ world renowned cannabis experts, users will discover an endless resource of facts and credible information about cannabis. Featuring a new “Cannabis for Ailments Series” designed to help people who are suffering from different health conditions like cancer, chronic pain, depression, anxiety, epilepsy, PTSD, Diabetes, ADD, and more, this new original series will safely and effectively show people how cannabis can help with their specific conditions.

“People around the globe are very interested in understanding the benefits of cannabis. Unfortunately, very few have enough trustworthy information about how it actually works for different ailments and conditions. Green Flower gives people unlimited access to renowned cannabis experts, doctors, scientists, and researchers delivered via video so you can watch anywhere in the world, right from the comfort of your home,” said Max Simon, CEO of Green Flower.

Other expert-led content being introduced on the new Green Flower platform includes “How to grow your own cannabis”, “Cooking with cannabis”, “Cannabis 101” “Understanding cannabis products”, “How cannabis interacts in the body”, “CBD 101”, and much more.

“Although there are changes taking place globally, with millions of people now gaining legal access to cannabis, it remains a fact that there continues to be an enormous amount of misconceptions, bad information, and stigma when it comes to marijuana,” said Max Simon, CEO Of Green Flower. “That’s why we created this streaming video platform. To stop the ignorance, spread trustworthy knowledge, and help people improve the quality of their lives through cannabis.”

New to the platform, and recently announced, is the “Showcases” segment. A place for cannabis companies to explicitly talk about their products and services without fear or censorship by social media platforms. Created for cannabis entrepreneurs and businesses seeking to ‘’showcase’’ their particular cannabis products or services, “Showcases” will allow cannabis companies a marketing platform that’s targeted, safe, and effective to advertise their solutions and reach their customers at scale.

Media Contact: Sabrina Propper; Director of Publicity: sabrina@green-flower.com

Established in 2014, Ventura-based Green Flower is the world’s largest video platform, maintaining 150+ affiliates to date.  Dedicated to introducing only trusted cannabis knowledge, the platform boasts over 1,000+ hours of high-quality video content featuring 600+ top cannabis industry experts, doctors, scientists, entrepreneurs, and thought-leaders.  Serving both consumers and professionals, Green Flower is the go-to platform for understanding every aspect of cannabis today.

 


William SumnerWilliam SumnerMay 8, 2018
aurora2.png

3min4620

Today, Aurora Cannabis Inc. (ACB) announced its financial results for the third fiscal quarter of 2018, ending on March 31, 2018.

The company completed the acquisition of CanniMed Therapeutics, one of the largest medical cannabis providers in Canada. Additionally, the company also completed strategic investments in Liquor Stores NA and The Green Organic Dutchman, in preparation for the launch of adult use cannabis sales in Canada later this summer.

“With production underway at Aurora Vie and Aurora Sky, yield enhancements being implemented at CanniMed, and significant new capacity coming online through 2018, we are targeting further, accelerated growth in subsequent quarters.,” commented Aurora CEO Terry Booth.

The company saw a large increase in the number of medical cannabis patients it served, surging 45,776 patients and representing a 249% increase. The sudden influx of medical cannabis patients was for the large part due to the company’s acquisition of CanniMed Therapeutics, which contributed 21, 327 patients.

The cost per gram to produce cannabis increased by 8.5%, from $1.41 to $1.53. Likewise, the cash cost of sales per gram also increased by 3.4%, from $1.74 to $1.80. Despite the increase in production and sales costs, the average selling price per gram declined by 4.4% to $7.99. Unsurprisingly, gross margins on cannabis produced by the company declined from 73.8% to 66%.

Revenue for the quarter was $16.1 million, representing a 37.6% increase compared to the previous quarter. Sales from cannabis rose by 11% to $10.8 million, with the majority of the coming from the Canadian market ($6.3 million). As of March 31, 2018, the company has approximately $338.5 million in working capital, compared to $170.1 million on June 30, 2017.

Despite the increase of revenue, losses for the company were quite high. The company reported a net loss of $20.8 million. The quarterly loss was largely attributed to share-based payments and the costs associated with acquiring CanniMed Therapeutics. Aurora ended up paying a premium for CanniMed as the hostile takeover caused the price of the acquisition to rise. With such high losses, Aurora has placed a pretty big bet on their acquisitions; leaving many to wonder when, or if, they will start to see returns.


William SumnerWilliam SumnerApril 9, 2018
daily_hit004-1280x533.png

4min5880

Here are the today’s cannabis news briefs for April 9, 2018:

Innovative Industrial Properties
Innovative Industrial Properties (IIPR), a provider real estate capital solutions for the medical cannabis industy, announced today that it has closed on the acquisition of a 89,000 square foot property in Scranton, Pennsylvania, for a price of approximately $5.8 million. The tenant of the property is a subsidiary company owned by Vireo Health, Inc., and is expected to reimburse Innovative approximately $2.8 million for improvements to the building. “We are very pleased to close on this third transaction with Vireo Health in Pennsylvania, projected by many to become one of the largest medical-use cannabis markets in the country,” said Ben Regin, Director of Investments and Finance for Innovative in a statement.

Canopy Growth Corporation

Canopy Growth Corporation (WEED) announced a partnership between its affiliate and biopharmaceutical research arm Canopy Health Innovations and drug research pioneer Lady Amanda Feilding and the Beckley Foundation (“Beckley”). Named Beckley Canopy, the partnership will work towards the research and development of clinically approved cannabis-based medicines. All profits from the work will go towards scientific research and policy work of the Beckley Foundation.”We are delighted to have formed this partnership with Beckley. They have been leading the way in drug policy reform and cannabis research for more than two decades and we feel that our skill-sets complement each other perfectly. This is a unique opportunity to expand our operations, conduct world-class research, and meet the needs of doctors and patients around the world,” said Canopy Health CEO, Marc Wayne.

Namaste Technologies Inc.
Namaste Technologies Inc. (N) announced that it has signed an amended Letter of Intent (LOI), dated April 4, 2018. Under the amended LOI, 2624078 Ontario Inc. will apply for an ACMPR license to cultivate medical cannabis and to sell medical cannabis oil. If the application is approve, the company will be able to test and develop its own cannabis strain for Cannmart. Additionally, 2624078 Ontario Inc. will rename itself Infinite Labz. “We’re pleased to have signed the amendment to the LOI as per our discussions with Namaste. We believe that our company and Namaste will see great value in this partnership and in operating both the LD and LP license from the same facility. There are many synergies that are evident between both parties and the addition of an ACMPR license to the facility at 7 Canso Road will solidify our position becoming a premier provider for medical and recreational cannabis oils and we look forward to a bright future with Namaste,” commented 2624078 Ontario Inc. president, Daniel Stern.


William SumnerWilliam SumnerFebruary 22, 2018
freedomLeaf-1280x874.png

3min7670

On Feb. 22, 2018, Freedom Leaf Inc. (FRLF) announced that it had filed its 10Q for the quarter ending December 31, 2017, yet the company included no financial information in the press release. In the filing, the company reported revenue for the quarter at $6,332 versus last year’s $448,566. Freedom Leaf delivered a net loss of $742,413 for the quarter versus last year’s loss $111,361 for the same time period.

In the filing, the company stated, “As of December 31, 2017, the Company had $0 in cash. We do not have sufficient resources to effectuate our business.” It went on to say, “We will have to raise funds to pay for our expenses. We may have to borrow money from shareholders or issue debt or equity or enter into a strategic arrangement with a third party. ” The company has an accumulated deficit of $6.3 million. It has also been issuing stock to pay for services, which is never a good sign.

Management’s Statement

The company also announced that it would soon launch its CBD product line, Hempology, in 10 US states; including California, Nevada, Washington, Oregon, Texas, Michigan, Georgia, and Alaska.

“Thanks to the efforts of our new CFO and our team, we now expect to move quickly into a new phase of the Company’s development as we continue to acquire and integrate additional revenue-producing companies,” said Freedom Leaf President and CEO, Clifford Perry, in a statement. “This 10Q is only a stepping stone to our goal to become debt free and move forward with our new revenue streams: Hempology and Leafceuticals.”

To meet production demands, the company’s wholly owned division, Leafceuticals, Inc. operates a NuAxon industrial CO2 supercritical extraction facility in North Las Vegas. So far the facility has produced 12 kilos, valued at $200,000, and expects to replicate those figures on a monthly basis.

The company is also the publisher of Freedom Leaf magazine. For six months ending December 31, 2017, the magazine only recorded revenue of $5,826, while the costs related to the magazine were $68,850.

Stockwise, the company has been on a roller coaster over the last month. In mid-January, Freedom Leaf’s stock began to soar, peaking out at $0.43 per share before taking a precipitous tumble down to $0.22 per share. During that peak period, the company retired approximately $167,748 in debt and accrued wages through the issuance of approximately 5.4 million common shares.


Debra BorchardtDebra BorchardtNovember 24, 2017
aurora5.png

6min11400

Canadian-based Aurora Cannabis Inc. (ACBFF)  has gone a spending spree as the company continues to make acquisitions. Yesterday, while all of us Americans were bonding over turkey, Aurora announced it had entered into a binding share purchase agreement to acquire H2 Biopharma Inc.

The Lachute, Quebec-based H2 is currently completing a purpose-built 48,000 square foot cannabis production facility, less than an hour from Montreal, and near the Pierre-Elliott Trudeau International Airport. The Lachute Facility is expected to be completed by the end of the year and is projected to produce 4,500 kilograms of high-quality cannabis per year. The facility is located on 46 acres of land, which H2 has the right to acquire for $136,000. The Lachute facility has access to ample low-cost power, water and infrastructure to support a very significant capacity expansion – up to or beyond the scale of the Company’s 800,000 square foot Aurora Sky facility, currently under construction near Edmonton International Airport.

“This is another outstanding transaction that further extends Aurora’s lead in establishing advanced-technology, ultra-efficient, low-cost production via purpose-built facilities,” said Terry Booth, CEO. “The Lachute Facility, which is 80% complete and has the land and utilities required for significant additional expansion, is fully consistent with the Aurora Standard and will be instrumental in delivering high-quality products for the Quebec, Canadian and overseas markets.”

This latest Aurora acquisition will be the Company’s fourth production facility in Canada – and the second site in Quebec, in addition to its 40,000 square foot production “Aurora Vie” facility in Pointe-Claire, on the island of Montreal.

Larssen Acquisition

Aurora also announced that it has signed a definitive agreement for the acquisition of 100% of the issued and outstanding shares of Larssen Ltd., a Canadian company that has consulted on the design, engineering, and construction oversight of many greenhouse cultivation facilities.  Larssen will be integrated into a newly incorporated subsidiary, Aurora Larssen Projects Ltd. and will focus on providing a turn-key service offering to Aurora and its domestic and international partners.

Booth added, “The acquisition of Larssen is an immediately accretive, high-margin revenue generating opportunity that also extends our technological leadership in the cannabis sector. We know Thomas and his team very well, as they have been instrumental in the design and engineering of our revolutionary Aurora Sky facility. This will help make the integration of Larssen with Aurora seamless. The establishment of ALPS will add significant capacity to our project execution team, enabling us to further accelerate the expansion of our global presence.”

Hempco Deal Completed

Aurora Cannabis announced that it has completed a non-brokered private placement with Hempco Food and Fiber Inc. for gross proceeds of $3.2 million that was originally announced in September. In relation to the placement, Hempco issued 10,558,676 units, at $0.3075 per unit, to Aurora. According to the company statement, “Each unit consists of one Hempco common share and one non-transferable common share purchase warrant. Each Warrant entitles Aurora to purchase one additional Hempco Share at a price of $0.41 until the second anniversary of the closing date. Each Warrant includes an acceleration clause, providing that if at any time beginning four months and one day after the date the warrant was issued the volume weighted average price per Hempco share on the TSX Venture Exchange (“TSXV”) exceeds $0.65 for a period of 30 consecutive calendar days, Hempco will have a limited right to accelerate the expiration date of the Warrants.”

This all comes as Aurora formally launched its hostile takeover bid for CanniMed Therapeutics. CanniMed had said earlier that while Aurora had expressed interest in a takeover, it hadn’t received a formal request. Aurora disputed that, but today issued a statement saying, “Notice and advertisement of the Offer was placed in the November 24, 2017 edition of the Globe & Mail, and a takeover bid circular will be mailed to CanniMed shareholders. In addition, Aurora will file the offer and takeover bid circular and related documents on SEDAR. The Offer Documents will also be available on Aurora’s website at www.auroramj.com and shareholders are invited to visit cannimed.auroramj.com for further information.”

 


Debra BorchardtDebra BorchardtOctober 4, 2017
22069997_137629820309698_2753495918488584192_n1.jpg

5min19290

As the concentrate market grows among cannabis consumers, brands are finding that the customers are demanding a better product. Typically, extraction products or cannabis oils in vape pens use the trim, which is basically the marijuana trash. It’s the leaves that end up on the floor of the grow facilities after the trimmers take the good stuff for flower sales.

Joey Shepp, Chief Executive Officer of Humboldt’s Finest said, “Trim used to be thrown away. It was practically free.” Since many producers believed all cannabis oil is basically the same, trim was a profitable choice for a base vape product, while the nice flower was sold separately. However, the popularity of vaporizers because of their cleanliness and convenience is causing a decline in flower sales and an increase in concentrate sales.

Now, customers are pushing back and demanding a better vape experience and that means they want better product going into the oil. Brendan Baker, Founder & CEO of Sunfed Inc., which produces Bumblebee Vape said that with whole plant extraction, consumers are getting a cleaner, truer representation of what the flower is like. “It has a higher cannabinoid content and a higher terpene profile,” he said. “Whole plant extraction, when done properly, gives consumers a better product and better consistency.”

While there is definitely a trend of buyers equating price with cannabinoid content, i.e. “I want the most THC for the least amount of cost,” Baker said the market is shifting. “Sure you can buy 150 proof alcohol, but how does it taste? What’s starting to happen is that people are reintroducing terpenes back into the oil.” Some will argue, that at the end of the distillation process, it’s all the same and when compared to the alcohol market, the same can be said. Yet, there are numerous variations in the spirits market that capitalize on taste and alcohol content.

Another dynamic that is pushing the increased amount of whole plant extraction is scale. “As farmers are scaling up and the amount of pounds they are producing is rising, it’s just more efficient to do whole plant extraction.” He noted that trimming is a labor intensive job, that works on a small scale, but won’t work as California ramps up. “It’s being pushed from craft to a more industrial sized scale,” he said. “They are actually running out of waste product to trim.”

With sun grown farmers seeing margins getting lower anything they can do to cut costs is welcome, including selling the whole plant to processors. However, it does take a certain amount of retooling at the farm to deliver the whole plant and so the farms that are early adopters and first to market will benefit from the switchover. Even on the processor side, Shepp said it takes a higher skill set to do whole plant extractions versus labs that are just distilling trim. “You could do that in a garage,” he added.  The change also brings a new dynamic as to pricing the whole plant when before prices were based on flower vs. trim.

The farmers seem to be pleased with the change. While prices could be lower, the costs are lower as well. Like any farmer, they are generally happier to lock in fewer customers and less processing in order to focus on farming.

“It’s a win-win. A win for the farmer, a win for manufacturing and a win for consumers who get a better product,” said Baker. “It’s Whole Foods versus processed foods.” As the story continues to be about the clean and pure product, Humboldt’s Finest comes to mind. Consumers want to know the farm now and whether it’s sustainable and clean. Baker mentioned they may do bulk oil from Humboldt’s Finest that could be used in other products. Saying it’s quality in and quality out.



About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 15 hours

My week on Twitter 🎉: 10 Mentions, 11.9K Mention Reach, 19 Likes, 7 Retweets, 85.4K Retweet Reach. See yours with…

@GreenMarketRpt – 22 hours

$CGC acquires $ACRG.U BUT not until cannabis is legal in the U.S.

Back to Top

You have Successfully Subscribed!